Trump's RFK appointment sends stock market into meltdown - as his full plan to 'make America healthy again' is revealed
Donald Trump's appointment of Robert F Kennedy Junior as his most senior health chief sent shares of major drug companies ...
Modern Healthcare4h
Trump selects RFK Jr. to head HHS
Robert F. Kennedy has espoused a number of unorthodox views on public health, most notably questioning the safety and ...
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data
Syndax Pharmaceuticals SNDX announced positive top-line results for revumenib, an oral small-molecule menin inhibitor, from the AUGMENT-101 study. The results were announced from the relapsed or ...
cidrap.umn2d
Cardiac inflammation markers show role of long-COVID symptoms
Novavax yesterday announced that the US Food and Drug Administration (FDA) has released a clinical hold on its new drug ...
cidrap.umn2d
H9N2 avian flu infects 7 more in China
China has reported seven more H9N2 avian flu infections in humans, mostly involving children and all in people whose symptoms ...
WPTV-TV2d
With holidays coming up, now is a good time to get flu and COVID-19 vaccines
Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters — they're not just another dose of ...
Novavax sees weak Covid vaccine sales, convinced Sanofi can do better
Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...
Novavax Gains Competitive Edge with FDA Clearance and Strategic Collaborations, Earning Buy Rating
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Novavax (NVAX – Research Report) today and set a price target of ...
emjreviews.com2d
FDA Lifts Hold on COVID-Flu Combo Vaccine Trial
The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...
Becker's Hospital Review2d
FDA lifts clinical hold on combined COVID-19-influenza vaccine trials
Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC) and standalone influenza vaccines. The FDA lifted a clinical hold that ...
Novavax, Inc. (NVAX) Q3 2024 Earnings Call Transcript
Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...